Superworth

Omeros EPS OMER

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
$1.52
Latest quarter, Q2 FY26
$0.15
Fiscal year 2025
−$0.26

Omeros' earnings per share was $1.52 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $0.15.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.26n/a
FY2024−$2.70−460%
FY2022$0.75−76%
FY2021$3.09n/a
FY2020−$2.40n/a
FY2019−$1.70n/a
FY2018−$2.61n/a
FY2017−$1.17n/a
FY2016−$1.65n/a
FY2015−$2.00n/a
FY2014−$2.22n/a
FY2013−$1.39n/a
FY2012−$1.59n/a
FY2011−$1.29n/a
FY2010n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.15n/a$1.52
Q1 FY26$0.62n/a$0.94
Q4 FY25$1.22n/a−$0.26
Q3 FY25−$0.47n/a−$2.02
Q2 FY25−$0.43n/a−$2.11
Q1 FY25−$0.58n/a−$2.65
Q4 FY24−$0.54n/a−$2.70
Q3 FY24−$0.56n/an/a
Q2 FY24−$0.97n/an/a
Q1 FY24−$0.63n/an/a
Q2 FY23−$0.59n/a$0.64
Q1 FY23−$0.54n/a$0.74

Against its peers

Companies in Drug Manufacturers - General nearest Omeros' size, closest first, today.

CompanyEPS, 12 monthsGrowth
OMEROmeros$1.52
AMPHAmphastar Pharmaceuticals$1.70−36% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
PAHCPhibro Animal Health$2.44+107% a year
ANIPANI Pharmaceuticals$4.70
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
HRMYHarmony Biosciences$3.09−0% a year
PBHPrestige Consumer Healthcare$3.57−16% a year
CRMDCorMedix$2.13+184% a year
Peer median$2.29

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Omeros

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.